Loading company
Loading
Open Financials CEREBAIN BIOTECH CORP. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Cash from operating activities | -$750,012 | -$664,900 | 10-K 2018-09-26 · proof | |
| Total assets | $91,601 | $236,862 | -61.3% | 10-K 2018-09-26 · proof |
| Total liabilities | $5.7 million | $4.5 million | +26.4% | 10-K 2018-09-26 · proof |
| Cash and cash equivalents | $64,583 | $11,345 | +469.3% | 10-K 2018-09-26 · proof |
- What was CEREBAIN BIOTECH CORP.'s cash from operating activities in fiscal 2018?
- CEREBAIN BIOTECH CORP. reported cash from operating activities of -$750,012 for fiscal 2018 (the year ended Jun 30, 2018), against -$664,900 the year before. Source: the 10-K filed with the SEC on Sep 26, 2018. SEC
- What are CEREBAIN BIOTECH CORP.'s total assets?
- As of Jun 30, 2018, CEREBAIN BIOTECH CORP. reported total assets of $91,601, against $236,862 a year earlier (-61.3%). Source: the 10-K filed with the SEC on Sep 26, 2018. SEC
- What are CEREBAIN BIOTECH CORP.'s total liabilities?
- As of Jun 30, 2018, CEREBAIN BIOTECH CORP. reported total liabilities of $5.7 million, against $4.5 million a year earlier (+26.4%). Source: the 10-K filed with the SEC on Sep 26, 2018. SEC
- What are CEREBAIN BIOTECH CORP.'s cash and cash equivalents?
- As of Jun 30, 2018, CEREBAIN BIOTECH CORP. reported cash and cash equivalents of $64,583, against $11,345 a year earlier (+469.3%). Source: the 10-K filed with the SEC on Sep 26, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1453099&period_type=annual&limit=5"Information only, not investment advice.